

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.87223709 |
| 2 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.85942273 |
| 3 | regulation of cell communication by electrical coupling (GO:0010649) | 3.65656508 |
| 4 | neuronal action potential propagation (GO:0019227) | 3.63457747 |
| 5 | insulin secretion (GO:0030073) | 3.59934114 |
| 6 | cell communication involved in cardiac conduction (GO:0086065) | 3.58932924 |
| 7 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.58203932 |
| 8 | auditory receptor cell differentiation (GO:0042491) | 3.55211855 |
| 9 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.52760843 |
| 10 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.50039548 |
| 11 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.47689683 |
| 12 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.45435844 |
| 13 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.44638718 |
| 14 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.42677520 |
| 15 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.40754563 |
| 16 | glycerophospholipid catabolic process (GO:0046475) | 3.39599897 |
| 17 | macroautophagy (GO:0016236) | 3.37485757 |
| 18 | positive regulation of respiratory burst (GO:0060267) | 3.34469225 |
| 19 | glucocorticoid biosynthetic process (GO:0006704) | 3.32793729 |
| 20 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.24374634 |
| 21 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 3.23389112 |
| 22 | peptide hormone processing (GO:0016486) | 3.22933187 |
| 23 | cellular ketone body metabolic process (GO:0046950) | 3.22316216 |
| 24 | endocrine pancreas development (GO:0031018) | 3.20839792 |
| 25 | positive regulation of glycolytic process (GO:0045821) | 3.19816859 |
| 26 | plasma membrane repair (GO:0001778) | 3.17377429 |
| 27 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.14269405 |
| 28 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.10617264 |
| 29 | synaptic vesicle exocytosis (GO:0016079) | 3.08814840 |
| 30 | sarcomere organization (GO:0045214) | 3.05945433 |
| 31 | positive regulation of insulin secretion (GO:0032024) | 3.05126492 |
| 32 | vocalization behavior (GO:0071625) | 3.04596875 |
| 33 | proline transport (GO:0015824) | 3.04159835 |
| 34 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.02803215 |
| 35 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.02487996 |
| 36 | dendritic spine morphogenesis (GO:0060997) | 3.01165337 |
| 37 | neuron cell-cell adhesion (GO:0007158) | 3.01152627 |
| 38 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.00991615 |
| 39 | negative regulation of hormone biosynthetic process (GO:0032353) | 3.00827669 |
| 40 | membrane repolarization during action potential (GO:0086011) | 3.00671422 |
| 41 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.99515026 |
| 42 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.99141222 |
| 43 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.98746379 |
| 44 | nitric oxide mediated signal transduction (GO:0007263) | 2.96899656 |
| 45 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.95502862 |
| 46 | positive regulation of potassium ion transport (GO:0043268) | 2.90742695 |
| 47 | chemosensory behavior (GO:0007635) | 2.90473428 |
| 48 | synaptic vesicle maturation (GO:0016188) | 2.88783544 |
| 49 | regulation of actin filament-based movement (GO:1903115) | 2.88734664 |
| 50 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.88500242 |
| 51 | toxin metabolic process (GO:0009404) | 2.86857429 |
| 52 | neuronal action potential (GO:0019228) | 2.86840009 |
| 53 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.85450951 |
| 54 | thyroid hormone metabolic process (GO:0042403) | 2.84942595 |
| 55 | regulation of relaxation of muscle (GO:1901077) | 2.84512567 |
| 56 | glutamate secretion (GO:0014047) | 2.84420722 |
| 57 | ketone body metabolic process (GO:1902224) | 2.82590502 |
| 58 | respiratory electron transport chain (GO:0022904) | 2.82281311 |
| 59 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.80736540 |
| 60 | positive regulation of peptide hormone secretion (GO:0090277) | 2.79457147 |
| 61 | detection of calcium ion (GO:0005513) | 2.79099511 |
| 62 | peptide hormone secretion (GO:0030072) | 2.78623841 |
| 63 | mating behavior (GO:0007617) | 2.77008361 |
| 64 | positive regulation of action potential (GO:0045760) | 2.76718087 |
| 65 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.75740438 |
| 66 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.75740438 |
| 67 | electron transport chain (GO:0022900) | 2.74392219 |
| 68 | cell communication by electrical coupling (GO:0010644) | 2.72173166 |
| 69 | positive regulation of peptide secretion (GO:0002793) | 2.71763379 |
| 70 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.71753054 |
| 71 | peptide secretion (GO:0002790) | 2.71691969 |
| 72 | cell migration in hindbrain (GO:0021535) | 2.71381754 |
| 73 | potassium ion export (GO:0071435) | 2.71338352 |
| 74 | inositol phosphate catabolic process (GO:0071545) | 2.70300182 |
| 75 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.70177997 |
| 76 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.70177997 |
| 77 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.69995344 |
| 78 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.69531821 |
| 79 | glandular epithelial cell differentiation (GO:0002067) | 2.69480317 |
| 80 | neuron recognition (GO:0008038) | 2.68974798 |
| 81 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.68950052 |
| 82 | membrane depolarization during action potential (GO:0086010) | 2.68404849 |
| 83 | regulation of membrane repolarization (GO:0060306) | 2.67970671 |
| 84 | negative regulation of hormone metabolic process (GO:0032351) | 2.67830124 |
| 85 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.67604803 |
| 86 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.66799462 |
| 87 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.66449017 |
| 88 | phenylpropanoid metabolic process (GO:0009698) | 2.64780616 |
| 89 | epithelial cell fate commitment (GO:0072148) | 2.64291829 |
| 90 | regulation of insulin secretion (GO:0050796) | 2.63213368 |
| 91 | neurofilament cytoskeleton organization (GO:0060052) | 2.63139459 |
| 92 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.62107946 |
| 93 | inositol phosphate dephosphorylation (GO:0046855) | 2.62107946 |
| 94 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.62095332 |
| 95 | regulation of cardiac muscle contraction (GO:0055117) | 2.61252912 |
| 96 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.59786382 |
| 97 | ATP synthesis coupled proton transport (GO:0015986) | 2.59786382 |
| 98 | cellular response to epinephrine stimulus (GO:0071872) | 2.59681339 |
| 99 | positive regulation of calcium ion import (GO:0090280) | 2.57629638 |
| 100 | negative regulation of protein localization to cell surface (GO:2000009) | 2.56442526 |
| 101 | neurotransmitter catabolic process (GO:0042135) | 2.56194126 |
| 102 | regulation of potassium ion transmembrane transport (GO:1901379) | 2.55812156 |
| 103 | regulation of striated muscle contraction (GO:0006942) | 2.55614460 |
| 104 | transcytosis (GO:0045056) | 2.54680076 |
| 105 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.54526386 |
| 106 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.54508771 |
| 107 | response to dietary excess (GO:0002021) | 2.54182215 |
| 108 | cardiac muscle contraction (GO:0060048) | 2.53918927 |
| 109 | parturition (GO:0007567) | 2.53617352 |
| 110 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.52730516 |
| 111 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.52667358 |
| 112 | negative regulation of cation channel activity (GO:2001258) | 2.52151943 |
| 113 | positive regulation of digestive system process (GO:0060456) | 2.50888558 |
| 114 | cardiac conduction (GO:0061337) | 2.50058127 |
| 115 | membrane repolarization (GO:0086009) | 2.50025518 |
| 116 | positive regulation of neurotransmitter transport (GO:0051590) | 2.47269112 |
| 117 | sodium ion export (GO:0071436) | 2.46910176 |
| 118 | regulation of autophagic vacuole assembly (GO:2000785) | 2.45955302 |
| 119 | layer formation in cerebral cortex (GO:0021819) | 2.45552895 |
| 120 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.45002652 |
| 121 | cellular potassium ion homeostasis (GO:0030007) | 2.44094268 |
| 122 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 2.43802635 |
| 123 | action potential (GO:0001508) | 2.43083578 |
| 124 | nitric oxide biosynthetic process (GO:0006809) | 2.42360923 |
| 125 | response to epinephrine (GO:0071871) | 2.40451976 |
| 126 | regulation of energy homeostasis (GO:2000505) | 2.40388709 |
| 127 | positive regulation of gluconeogenesis (GO:0045722) | 2.39706792 |
| 128 | neuronal ion channel clustering (GO:0045161) | 2.39654870 |
| 129 | negative regulation of ion transmembrane transporter activity (GO:0032413) | 2.39556365 |
| 130 | regulation of peptide hormone secretion (GO:0090276) | 2.39431904 |
| 131 | multicellular organismal signaling (GO:0035637) | 2.39428241 |
| 132 | cardiac myofibril assembly (GO:0055003) | 2.39068274 |
| 133 | positive regulation of macroautophagy (GO:0016239) | 2.38989207 |
| 134 | axon ensheathment in central nervous system (GO:0032291) | 2.38689797 |
| 135 | central nervous system myelination (GO:0022010) | 2.38689797 |
| 136 | activation of protein kinase A activity (GO:0034199) | 2.38443602 |
| 137 | axonal fasciculation (GO:0007413) | 2.38125116 |
| 138 | glucocorticoid metabolic process (GO:0008211) | 2.37826018 |
| 139 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.37758346 |
| 140 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.37715096 |
| 141 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.37715096 |
| 142 | thyroid hormone generation (GO:0006590) | 2.37343781 |
| 143 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.37212666 |
| 144 | protein localization to synapse (GO:0035418) | 2.36572681 |
| 145 | type B pancreatic cell development (GO:0003323) | 2.36402888 |
| 146 | peptide transport (GO:0015833) | 2.36148022 |
| 147 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 2.35820516 |
| 148 | detection of temperature stimulus (GO:0016048) | 2.35652958 |
| 149 | regulation of peptide secretion (GO:0002791) | 2.35124837 |
| 150 | positive regulation of sodium ion transport (GO:0010765) | 2.33876745 |
| 151 | locomotory exploration behavior (GO:0035641) | 2.33535167 |
| 152 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.32449428 |
| 153 | cardiac muscle cell action potential (GO:0086001) | 2.31596961 |
| 154 | establishment of mitochondrion localization (GO:0051654) | 2.30512055 |
| 155 | regulation of cation channel activity (GO:2001257) | 2.28807671 |
| 156 | membrane assembly (GO:0071709) | 2.27924924 |
| 157 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.27866109 |
| 158 | regulation of heart rate (GO:0002027) | 2.26628072 |
| 159 | potassium ion homeostasis (GO:0055075) | 2.26171632 |
| 160 | potassium ion import (GO:0010107) | 2.26149673 |
| 161 | cerebellar Purkinje cell layer development (GO:0021680) | 2.25909226 |
| 162 | regulation of Rac protein signal transduction (GO:0035020) | 2.20085725 |
| 163 | negative regulation of neurological system process (GO:0031645) | 2.19847811 |
| 164 | regulation of vacuole organization (GO:0044088) | 2.19297616 |
| 165 | hormone secretion (GO:0046879) | 2.18623126 |
| 166 | calcium ion import (GO:0070509) | 2.17014342 |
| 167 | neurotransmitter secretion (GO:0007269) | 2.17005147 |
| 168 | sphingomyelin metabolic process (GO:0006684) | 2.16956573 |
| 169 | regulation of protein glycosylation (GO:0060049) | 2.15991701 |
| 170 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.15468433 |
| 171 | negative regulation of complement activation (GO:0045916) | 2.15327138 |
| 172 | regulation of hexokinase activity (GO:1903299) | 2.14472544 |
| 173 | regulation of glucokinase activity (GO:0033131) | 2.14472544 |
| 174 | polyol catabolic process (GO:0046174) | 2.14092441 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 5.17146396 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.04970297 |
| 3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.99569086 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.89261627 |
| 5 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.76098952 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.66870159 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.61572842 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.61572842 |
| 9 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.57598007 |
| 10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.48195792 |
| 11 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.43028378 |
| 12 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.37947139 |
| 13 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.29260597 |
| 14 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.26634590 |
| 15 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.22690986 |
| 16 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.22133942 |
| 17 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.05526879 |
| 18 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.99930512 |
| 19 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.98787383 |
| 20 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.94808851 |
| 21 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.91102842 |
| 22 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.90640434 |
| 23 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.86353607 |
| 24 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.76908157 |
| 25 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.68575374 |
| 26 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.66714000 |
| 27 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.66204826 |
| 28 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.55019119 |
| 29 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.51437424 |
| 30 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.51077172 |
| 31 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.49142489 |
| 32 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.46888578 |
| 33 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.44257144 |
| 34 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.44125039 |
| 35 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.43863300 |
| 36 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.42733227 |
| 37 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.42483597 |
| 38 | VDR_22108803_ChIP-Seq_LS180_Human | 1.41381148 |
| 39 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.40912868 |
| 40 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.40734314 |
| 41 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.40474460 |
| 42 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.38646075 |
| 43 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.38298641 |
| 44 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.37288487 |
| 45 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.32064922 |
| 46 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.31573013 |
| 47 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.31093893 |
| 48 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.30631276 |
| 49 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.28345105 |
| 50 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.28067370 |
| 51 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.27625400 |
| 52 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.25792023 |
| 53 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.25589523 |
| 54 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.24662387 |
| 55 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.24380008 |
| 56 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.23190285 |
| 57 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.23094708 |
| 58 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.22355449 |
| 59 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.20167752 |
| 60 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.19903172 |
| 61 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.18824263 |
| 62 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.18272664 |
| 63 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.18092376 |
| 64 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.16563558 |
| 65 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.16232600 |
| 66 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.14108483 |
| 67 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.14029965 |
| 68 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.13860020 |
| 69 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.13562745 |
| 70 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.13399422 |
| 71 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.13208176 |
| 72 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.12371624 |
| 73 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.12229493 |
| 74 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.11933103 |
| 75 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.11882960 |
| 76 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.11310888 |
| 77 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.11310888 |
| 78 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.08367984 |
| 79 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.07224938 |
| 80 | * CDX2_22108803_ChIP-Seq_LS180_Human | 1.06406998 |
| 81 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.05673647 |
| 82 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.05578271 |
| 83 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.04722908 |
| 84 | AR_25329375_ChIP-Seq_VCAP_Human | 1.04595437 |
| 85 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.04497479 |
| 86 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.04035474 |
| 87 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.03333863 |
| 88 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.03267323 |
| 89 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.02129466 |
| 90 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.01330996 |
| 91 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01211122 |
| 92 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.01170454 |
| 93 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.00663931 |
| 94 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.00636883 |
| 95 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.00164023 |
| 96 | * BCAT_22108803_ChIP-Seq_LS180_Human | 0.99739373 |
| 97 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.98871306 |
| 98 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.98834254 |
| 99 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.98348645 |
| 100 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.97864437 |
| 101 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.97830609 |
| 102 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.97547976 |
| 103 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97300579 |
| 104 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.97221163 |
| 105 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.96637621 |
| 106 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.96303599 |
| 107 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.96036812 |
| 108 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.95938151 |
| 109 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95933193 |
| 110 | STAT3_23295773_ChIP-Seq_U87_Human | 0.95915306 |
| 111 | TP53_16413492_ChIP-PET_HCT116_Human | 0.95422527 |
| 112 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.95037633 |
| 113 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.94818740 |
| 114 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.94290633 |
| 115 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.94053151 |
| 116 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.92940759 |
| 117 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.92471083 |
| 118 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.92076388 |
| 119 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.92047223 |
| 120 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.90911871 |
| 121 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.89623756 |
| 122 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.87841158 |
| 123 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.87301846 |
| 124 | AR_19668381_ChIP-Seq_PC3_Human | 0.87184151 |
| 125 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.87085817 |
| 126 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.84302181 |
| 127 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.84227229 |
| 128 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.84020850 |
| 129 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.83958419 |
| 130 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.82971738 |
| 131 | TCF4_23295773_ChIP-Seq_U87_Human | 0.82943728 |
| 132 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.82615175 |
| 133 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.81884466 |
| 134 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.81690280 |
| 135 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.81663217 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 3.88358955 |
| 2 | MP0003787_abnormal_imprinting | 3.67974671 |
| 3 | MP0002735_abnormal_chemical_nociception | 3.24109998 |
| 4 | MP0004859_abnormal_synaptic_plasticity | 3.23779001 |
| 5 | MP0000751_myopathy | 3.10598343 |
| 6 | MP0005379_endocrine/exocrine_gland_phen | 2.98781669 |
| 7 | MP0003880_abnormal_central_pattern | 2.96047557 |
| 8 | MP0004270_analgesia | 2.82005474 |
| 9 | MP0001968_abnormal_touch/_nociception | 2.73447882 |
| 10 | MP0003283_abnormal_digestive_organ | 2.61885821 |
| 11 | MP0002163_abnormal_gland_morphology | 2.55068776 |
| 12 | MP0003123_paternal_imprinting | 2.51565241 |
| 13 | MP0002736_abnormal_nociception_after | 2.50279503 |
| 14 | MP0004084_abnormal_cardiac_muscle | 2.38853351 |
| 15 | MP0002734_abnormal_mechanical_nocicepti | 2.37797927 |
| 16 | MP0004036_abnormal_muscle_relaxation | 2.28714625 |
| 17 | MP0003635_abnormal_synaptic_transmissio | 2.28016703 |
| 18 | MP0003195_calcinosis | 2.22176058 |
| 19 | MP0004858_abnormal_nervous_system | 2.19420163 |
| 20 | MP0004215_abnormal_myocardial_fiber | 2.15302496 |
| 21 | MP0002733_abnormal_thermal_nociception | 2.09358482 |
| 22 | MP0001944_abnormal_pancreas_morphology | 2.07845019 |
| 23 | MP0006276_abnormal_autonomic_nervous | 2.06203905 |
| 24 | MP0000749_muscle_degeneration | 2.04711462 |
| 25 | MP0002272_abnormal_nervous_system | 2.03754689 |
| 26 | MP0003329_amyloid_beta_deposits | 1.97861566 |
| 27 | MP0002064_seizures | 1.91831821 |
| 28 | MP0001970_abnormal_pain_threshold | 1.91062326 |
| 29 | MP0009745_abnormal_behavioral_response | 1.90621627 |
| 30 | MP0004043_abnormal_pH_regulation | 1.89306681 |
| 31 | MP0005646_abnormal_pituitary_gland | 1.88959084 |
| 32 | MP0009046_muscle_twitch | 1.84215327 |
| 33 | MP0003646_muscle_fatigue | 1.82885026 |
| 34 | MP0002139_abnormal_hepatobiliary_system | 1.81543412 |
| 35 | MP0002693_abnormal_pancreas_physiology | 1.77975346 |
| 36 | MP0004145_abnormal_muscle_electrophysio | 1.76411101 |
| 37 | MP0002972_abnormal_cardiac_muscle | 1.68582170 |
| 38 | MP0010386_abnormal_urinary_bladder | 1.67004294 |
| 39 | MP0001440_abnormal_grooming_behavior | 1.65726582 |
| 40 | MP0002063_abnormal_learning/memory/cond | 1.64228373 |
| 41 | MP0000747_muscle_weakness | 1.63463705 |
| 42 | MP0004484_altered_response_of | 1.61637802 |
| 43 | MP0001756_abnormal_urination | 1.60700868 |
| 44 | MP0005330_cardiomyopathy | 1.58312663 |
| 45 | MP0001348_abnormal_lacrimal_gland | 1.54313807 |
| 46 | MP0005620_abnormal_muscle_contractility | 1.52839225 |
| 47 | MP0003011_delayed_dark_adaptation | 1.51213976 |
| 48 | MP0003137_abnormal_impulse_conducting | 1.51154022 |
| 49 | MP0002638_abnormal_pupillary_reflex | 1.50131749 |
| 50 | MP0002254_reproductive_system_inflammat | 1.50029132 |
| 51 | MP0001501_abnormal_sleep_pattern | 1.48696681 |
| 52 | MP0002572_abnormal_emotion/affect_behav | 1.47563059 |
| 53 | MP0002078_abnormal_glucose_homeostasis | 1.47364323 |
| 54 | MP0002067_abnormal_sensory_capabilities | 1.47312759 |
| 55 | MP0008775_abnormal_heart_ventricle | 1.45530476 |
| 56 | MP0009780_abnormal_chondrocyte_physiolo | 1.45036560 |
| 57 | MP0001765_abnormal_ion_homeostasis | 1.44786444 |
| 58 | MP0004087_abnormal_muscle_fiber | 1.39052880 |
| 59 | MP0004085_abnormal_heartbeat | 1.37972109 |
| 60 | MP0002184_abnormal_innervation | 1.37686933 |
| 61 | MP0004019_abnormal_vitamin_homeostasis | 1.37630923 |
| 62 | MP0005623_abnormal_meninges_morphology | 1.37564231 |
| 63 | MP0003868_abnormal_feces_composition | 1.36545881 |
| 64 | MP0001486_abnormal_startle_reflex | 1.35347798 |
| 65 | MP0002876_abnormal_thyroid_physiology | 1.34182765 |
| 66 | MP0006138_congestive_heart_failure | 1.34060231 |
| 67 | MP0002909_abnormal_adrenal_gland | 1.33817272 |
| 68 | MP0005645_abnormal_hypothalamus_physiol | 1.31760821 |
| 69 | MP0000003_abnormal_adipose_tissue | 1.31718238 |
| 70 | MP0000920_abnormal_myelination | 1.28713764 |
| 71 | MP0008569_lethality_at_weaning | 1.28013577 |
| 72 | MP0010329_abnormal_lipoprotein_level | 1.26627702 |
| 73 | MP0000462_abnormal_digestive_system | 1.25673776 |
| 74 | MP0000778_abnormal_nervous_system | 1.24180883 |
| 75 | MP0001905_abnormal_dopamine_level | 1.24063123 |
| 76 | MP0001984_abnormal_olfaction | 1.23935994 |
| 77 | MP0005503_abnormal_tendon_morphology | 1.21335673 |
| 78 | MP0008877_abnormal_DNA_methylation | 1.20758862 |
| 79 | MP0003953_abnormal_hormone_level | 1.19477743 |
| 80 | MP0004130_abnormal_muscle_cell | 1.19329847 |
| 81 | MP0001299_abnormal_eye_distance/ | 1.18119669 |
| 82 | MP0005448_abnormal_energy_balance | 1.17689538 |
| 83 | MP0002106_abnormal_muscle_physiology | 1.13539489 |
| 84 | MP0000013_abnormal_adipose_tissue | 1.12209714 |
| 85 | MP0004510_myositis | 1.11900763 |
| 86 | MP0004924_abnormal_behavior | 1.11743917 |
| 87 | MP0005386_behavior/neurological_phenoty | 1.11743917 |
| 88 | MP0003122_maternal_imprinting | 1.10929759 |
| 89 | MP0005636_abnormal_mineral_homeostasis | 1.09951044 |
| 90 | MP0004272_abnormal_basement_membrane | 1.09767447 |
| 91 | MP0001986_abnormal_taste_sensitivity | 1.09748582 |
| 92 | MP0000230_abnormal_systemic_arterial | 1.09501700 |
| 93 | MP0003879_abnormal_hair_cell | 1.08995662 |
| 94 | MP0005369_muscle_phenotype | 1.08007630 |
| 95 | MP0003121_genomic_imprinting | 1.07487128 |
| 96 | MP0005332_abnormal_amino_acid | 1.06535605 |
| 97 | MP0000759_abnormal_skeletal_muscle | 1.06455729 |
| 98 | MP0005220_abnormal_exocrine_pancreas | 1.06166817 |
| 99 | MP0000639_abnormal_adrenal_gland | 1.05462039 |
| 100 | MP0005551_abnormal_eye_electrophysiolog | 1.05035025 |
| 101 | MP0001346_abnormal_lacrimal_gland | 1.04213024 |
| 102 | MP0001502_abnormal_circadian_rhythm | 1.03107254 |
| 103 | MP0004782_abnormal_surfactant_physiolog | 1.02584201 |
| 104 | MP0002269_muscular_atrophy | 1.01998224 |
| 105 | MP0001664_abnormal_digestion | 0.99842068 |
| 106 | MP0001485_abnormal_pinna_reflex | 0.99797762 |
| 107 | MP0005385_cardiovascular_system_phenoty | 0.99360154 |
| 108 | MP0001544_abnormal_cardiovascular_syste | 0.99360154 |
| 109 | MP0000955_abnormal_spinal_cord | 0.98660079 |
| 110 | MP0003045_fibrosis | 0.98315963 |
| 111 | MP0004233_abnormal_muscle_weight | 0.97905290 |
| 112 | MP0008004_abnormal_stomach_pH | 0.97718667 |
| 113 | MP0002066_abnormal_motor_capabilities/c | 0.97580807 |
| 114 | MP0001529_abnormal_vocalization | 0.97197042 |
| 115 | MP0005365_abnormal_bile_salt | 0.96471511 |
| 116 | MP0002882_abnormal_neuron_morphology | 0.95993312 |
| 117 | MP0002822_catalepsy | 0.95875983 |
| 118 | MP0003633_abnormal_nervous_system | 0.92094677 |
| 119 | MP0010678_abnormal_skin_adnexa | 0.90985756 |
| 120 | MP0000631_abnormal_neuroendocrine_gland | 0.90346705 |
| 121 | MP0006072_abnormal_retinal_apoptosis | 0.89494710 |
| 122 | MP0005423_abnormal_somatic_nervous | 0.88801681 |
| 123 | MP0002118_abnormal_lipid_homeostasis | 0.87802508 |
| 124 | MP0004811_abnormal_neuron_physiology | 0.87576725 |
| 125 | MP0002108_abnormal_muscle_morphology | 0.86622903 |
| 126 | MP0002295_abnormal_pulmonary_circulatio | 0.85691301 |
| 127 | MP0003634_abnormal_glial_cell | 0.84420895 |
| 128 | MP0005275_abnormal_skin_tensile | 0.83905027 |
| 129 | MP0002557_abnormal_social/conspecific_i | 0.83653008 |
| 130 | MP0002234_abnormal_pharynx_morphology | 0.82575761 |
| 131 | MP0009643_abnormal_urine_homeostasis | 0.81754012 |
| 132 | MP0002090_abnormal_vision | 0.81126543 |
| 133 | MP0000750_abnormal_muscle_regeneration | 0.80940116 |
| 134 | MP0002229_neurodegeneration | 0.80894963 |
| 135 | MP0002971_abnormal_brown_adipose | 0.80687605 |
| 136 | MP0005253_abnormal_eye_physiology | 0.79883667 |
| 137 | MP0003172_abnormal_lysosome_physiology | 0.77000721 |
| 138 | MP0000538_abnormal_urinary_bladder | 0.76828989 |
| 139 | MP0000604_amyloidosis | 0.76569998 |
| 140 | MP0004142_abnormal_muscle_tone | 0.76267624 |
| 141 | MP0001270_distended_abdomen | 0.75965633 |
| 142 | MP0002127_abnormal_cardiovascular_syste | 0.75916189 |
| 143 | MP0004742_abnormal_vestibular_system | 0.74029190 |
| 144 | MP0005670_abnormal_white_adipose | 0.73467450 |
| 145 | MP0010630_abnormal_cardiac_muscle | 0.73408556 |
| 146 | MP0009384_cardiac_valve_regurgitation | 0.73045659 |
| 147 | MP0004885_abnormal_endolymph | 0.72979462 |
| 148 | MP0005165_increased_susceptibility_to | 0.71483533 |
| 149 | MP0010352_gastrointestinal_tract_polyps | 0.71263329 |
| 150 | MP0004147_increased_porphyrin_level | 0.69599426 |
| 151 | MP0010234_abnormal_vibrissa_follicle | 0.68764500 |
| 152 | MP0005535_abnormal_body_temperature | 0.68389176 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypoglycemic seizures (HP:0002173) | 4.37364120 |
| 2 | Hyperinsulinemic hypoglycemia (HP:0000825) | 4.33314771 |
| 3 | Focal motor seizures (HP:0011153) | 4.28423464 |
| 4 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 4.08694537 |
| 5 | Sudden death (HP:0001699) | 4.08335746 |
| 6 | Pheochromocytoma (HP:0002666) | 4.06257720 |
| 7 | Right ventricular cardiomyopathy (HP:0011663) | 4.04192038 |
| 8 | Myokymia (HP:0002411) | 4.01535143 |
| 9 | Decreased circulating renin level (HP:0003351) | 3.96396648 |
| 10 | Hyperglycemia (HP:0003074) | 3.94923654 |
| 11 | Hypoglycemic coma (HP:0001325) | 3.92029562 |
| 12 | Abnormality of renin-angiotensin system (HP:0000847) | 3.81226958 |
| 13 | Neuroendocrine neoplasm (HP:0100634) | 3.65681870 |
| 14 | Hyporeflexia of lower limbs (HP:0002600) | 3.64503800 |
| 15 | Ketoacidosis (HP:0001993) | 3.61706211 |
| 16 | Hyperactive renin-angiotensin system (HP:0000841) | 3.54719571 |
| 17 | Double outlet right ventricle (HP:0001719) | 3.53194525 |
| 18 | Congenital malformation of the right heart (HP:0011723) | 3.53194525 |
| 19 | Enlarged penis (HP:0000040) | 3.50584859 |
| 20 | Atonic seizures (HP:0010819) | 3.48896396 |
| 21 | Abnormal pancreas size (HP:0012094) | 3.37488661 |
| 22 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.37433633 |
| 23 | Late onset (HP:0003584) | 3.31125964 |
| 24 | Calf muscle hypertrophy (HP:0008981) | 3.29894755 |
| 25 | Muscle fiber splitting (HP:0003555) | 3.27080756 |
| 26 | Termporal pattern (HP:0011008) | 3.21958558 |
| 27 | Insidious onset (HP:0003587) | 3.21958558 |
| 28 | Increased circulating renin level (HP:0000848) | 3.19660281 |
| 29 | Large for gestational age (HP:0001520) | 3.19240071 |
| 30 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.17106352 |
| 31 | Focal seizures (HP:0007359) | 3.15196036 |
| 32 | Ulnar claw (HP:0001178) | 3.12915264 |
| 33 | Exercise-induced myalgia (HP:0003738) | 3.10446820 |
| 34 | Metabolic alkalosis (HP:0200114) | 3.08790253 |
| 35 | Myotonia (HP:0002486) | 3.07342122 |
| 36 | Abnormality of the calf musculature (HP:0001430) | 3.06614638 |
| 37 | Ventricular tachycardia (HP:0004756) | 3.04452256 |
| 38 | Hyperphosphatemia (HP:0002905) | 3.03212546 |
| 39 | Ventricular fibrillation (HP:0001663) | 3.03128810 |
| 40 | Syncope (HP:0001279) | 3.00797779 |
| 41 | Palpitations (HP:0001962) | 3.00344282 |
| 42 | Congenital sensorineural hearing impairment (HP:0008527) | 2.89725466 |
| 43 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.87779376 |
| 44 | Symptomatic seizures (HP:0011145) | 2.86614010 |
| 45 | Hyperthyroidism (HP:0000836) | 2.86437665 |
| 46 | Acute necrotizing encephalopathy (HP:0006965) | 2.82811362 |
| 47 | Hypokalemia (HP:0002900) | 2.79594991 |
| 48 | Hyperaldosteronism (HP:0000859) | 2.79145151 |
| 49 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.78516438 |
| 50 | Agitation (HP:0000713) | 2.75639592 |
| 51 | Atrial fibrillation (HP:0005110) | 2.74648484 |
| 52 | Foot dorsiflexor weakness (HP:0009027) | 2.70545726 |
| 53 | EMG: myopathic abnormalities (HP:0003458) | 2.68959215 |
| 54 | Epileptiform EEG discharges (HP:0011182) | 2.68733701 |
| 55 | EEG with generalized epileptiform discharges (HP:0011198) | 2.67218280 |
| 56 | Hypothermia (HP:0002045) | 2.64744698 |
| 57 | Primary atrial arrhythmia (HP:0001692) | 2.63376403 |
| 58 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.62686548 |
| 59 | Prolonged QT interval (HP:0001657) | 2.61916081 |
| 60 | Exercise-induced muscle cramps (HP:0003710) | 2.59822680 |
| 61 | Goiter (HP:0000853) | 2.59154308 |
| 62 | Metaphyseal dysplasia (HP:0100255) | 2.54041563 |
| 63 | Action tremor (HP:0002345) | 2.51930037 |
| 64 | Progressive macrocephaly (HP:0004481) | 2.51515902 |
| 65 | Abnormality of the foot musculature (HP:0001436) | 2.50681265 |
| 66 | Supranuclear gaze palsy (HP:0000605) | 2.49843012 |
| 67 | Supraventricular tachycardia (HP:0004755) | 2.48777610 |
| 68 | Increased CSF protein (HP:0002922) | 2.48718361 |
| 69 | Visual hallucinations (HP:0002367) | 2.48438314 |
| 70 | Abnormality of potassium homeostasis (HP:0011042) | 2.48350720 |
| 71 | Supraventricular arrhythmia (HP:0005115) | 2.46587080 |
| 72 | Ventricular arrhythmia (HP:0004308) | 2.44964606 |
| 73 | Febrile seizures (HP:0002373) | 2.44332542 |
| 74 | Hypsarrhythmia (HP:0002521) | 2.43978198 |
| 75 | Abnormality of vitamin B metabolism (HP:0004340) | 2.43483345 |
| 76 | Fetal akinesia sequence (HP:0001989) | 2.42502792 |
| 77 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.41580138 |
| 78 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.41580138 |
| 79 | Hemiparesis (HP:0001269) | 2.40190383 |
| 80 | Cerebral hemorrhage (HP:0001342) | 2.38465994 |
| 81 | Absence seizures (HP:0002121) | 2.38374885 |
| 82 | Testicular neoplasm (HP:0010788) | 2.37607980 |
| 83 | Bundle branch block (HP:0011710) | 2.37483240 |
| 84 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.37382453 |
| 85 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.37382453 |
| 86 | Hypercortisolism (HP:0001578) | 2.36481348 |
| 87 | Onion bulb formation (HP:0003383) | 2.35487414 |
| 88 | Neurofibrillary tangles (HP:0002185) | 2.33522582 |
| 89 | Ketosis (HP:0001946) | 2.32638092 |
| 90 | Cerebral inclusion bodies (HP:0100314) | 2.31426882 |
| 91 | Steppage gait (HP:0003376) | 2.31043643 |
| 92 | Hypomagnesemia (HP:0002917) | 2.28091949 |
| 93 | Abnormality of vitamin metabolism (HP:0100508) | 2.26442616 |
| 94 | Difficulty running (HP:0009046) | 2.26218866 |
| 95 | Abnormality of chloride homeostasis (HP:0011422) | 2.25002015 |
| 96 | Proximal tubulopathy (HP:0000114) | 2.22485960 |
| 97 | Adrenal overactivity (HP:0002717) | 2.21100673 |
| 98 | Increased variability in muscle fiber diameter (HP:0003557) | 2.20389277 |
| 99 | Lipoatrophy (HP:0100578) | 2.18478055 |
| 100 | Macroorchidism (HP:0000053) | 2.18424875 |
| 101 | Acute encephalopathy (HP:0006846) | 2.16783183 |
| 102 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.13500823 |
| 103 | Mucopolysacchariduria (HP:0008155) | 2.13500823 |
| 104 | Mitochondrial inheritance (HP:0001427) | 2.12570533 |
| 105 | Dialeptic seizures (HP:0011146) | 2.11574897 |
| 106 | Abnormality of the corticospinal tract (HP:0002492) | 2.10989620 |
| 107 | Myoglobinuria (HP:0002913) | 2.10762517 |
| 108 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.09686614 |
| 109 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.09686614 |
| 110 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.09686614 |
| 111 | Epileptic encephalopathy (HP:0200134) | 2.09539868 |
| 112 | Abnormality of magnesium homeostasis (HP:0004921) | 2.09105459 |
| 113 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.08428309 |
| 114 | Polydipsia (HP:0001959) | 2.07349867 |
| 115 | Abnormal drinking behavior (HP:0030082) | 2.07349867 |
| 116 | Menstrual irregularities (HP:0000858) | 2.07312345 |
| 117 | Bradycardia (HP:0001662) | 2.06092262 |
| 118 | Hepatoblastoma (HP:0002884) | 2.05752392 |
| 119 | Generalized tonic-clonic seizures (HP:0002069) | 2.05372114 |
| 120 | Tubular atrophy (HP:0000092) | 2.03941961 |
| 121 | Limb dystonia (HP:0002451) | 2.02821537 |
| 122 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.02641646 |
| 123 | Muscle stiffness (HP:0003552) | 2.01630982 |
| 124 | Hammertoe (HP:0001765) | 2.00802640 |
| 125 | Hematochezia (HP:0002573) | 1.95595700 |
| 126 | Rapidly progressive (HP:0003678) | 1.95246434 |
| 127 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.94898017 |
| 128 | Postural tremor (HP:0002174) | 1.94706796 |
| 129 | Progressive cerebellar ataxia (HP:0002073) | 1.93639499 |
| 130 | Abnormal EKG (HP:0003115) | 1.92755600 |
| 131 | Hyperparathyroidism (HP:0000843) | 1.92390710 |
| 132 | Distal arthrogryposis (HP:0005684) | 1.91220115 |
| 133 | Intention tremor (HP:0002080) | 1.91080439 |
| 134 | Sensory axonal neuropathy (HP:0003390) | 1.90255687 |
| 135 | Increased connective tissue (HP:0009025) | 1.89616160 |
| 136 | Ankle clonus (HP:0011448) | 1.89173443 |
| 137 | Malnutrition (HP:0004395) | 1.88295408 |
| 138 | Hyperkalemia (HP:0002153) | 1.87504843 |
| 139 | Dysmetria (HP:0001310) | 1.87259936 |
| 140 | Progressive neurologic deterioration (HP:0002344) | 1.86182337 |
| 141 | Asymmetric septal hypertrophy (HP:0001670) | 1.85905086 |
| 142 | Anxiety (HP:0000739) | 1.85751120 |
| 143 | Diminished movement (HP:0002374) | 1.85526325 |
| 144 | Hepatocellular necrosis (HP:0001404) | 1.85029393 |
| 145 | Dilated cardiomyopathy (HP:0001644) | 1.84907855 |
| 146 | Neoplasm of the adrenal cortex (HP:0100641) | 1.84380030 |
| 147 | Hypokinesia (HP:0002375) | 1.83604263 |
| 148 | Tachypnea (HP:0002789) | 1.83557200 |
| 149 | Hypoventilation (HP:0002791) | 1.82605153 |
| 150 | Retinal dysplasia (HP:0007973) | 1.82160339 |
| 151 | Atrophic scars (HP:0001075) | 1.80804254 |
| 152 | Glycosuria (HP:0003076) | 1.80004367 |
| 153 | Abnormality of urine glucose concentration (HP:0011016) | 1.80004367 |
| 154 | Peripheral hypomyelination (HP:0007182) | 1.79639139 |
| 155 | Synostosis involving the elbow (HP:0003938) | 1.79210325 |
| 156 | Humeroradial synostosis (HP:0003041) | 1.79210325 |
| 157 | Progressive inability to walk (HP:0002505) | 1.77585644 |
| 158 | Scanning speech (HP:0002168) | 1.77414294 |
| 159 | Vascular calcification (HP:0004934) | 1.76860830 |
| 160 | Papilledema (HP:0001085) | 1.76645658 |
| 161 | Urinary urgency (HP:0000012) | 1.74215165 |
| 162 | Polyphagia (HP:0002591) | 1.73700357 |
| 163 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.73687823 |
| 164 | Abnormality of pain sensation (HP:0010832) | 1.72984616 |
| 165 | Impaired pain sensation (HP:0007328) | 1.72984616 |
| 166 | Decreased motor nerve conduction velocity (HP:0003431) | 1.72107543 |
| 167 | Growth hormone excess (HP:0000845) | 1.70807336 |
| 168 | Increased CSF lactate (HP:0002490) | 1.70341142 |
| 169 | Hyponatremia (HP:0002902) | 1.70119908 |
| 170 | Abnormality of renal excretion (HP:0011036) | 1.69838481 |
| 171 | Scapular winging (HP:0003691) | 1.69556375 |
| 172 | Akinesia (HP:0002304) | 1.69553952 |
| 173 | Hyperphosphaturia (HP:0003109) | 1.68968395 |
| 174 | Intestinal atresia (HP:0011100) | 1.67772068 |
| 175 | Truncal ataxia (HP:0002078) | 1.67689887 |
| 176 | Hypotension (HP:0002615) | 1.66702963 |
| 177 | Abnormality of the vocal cords (HP:0008777) | 1.66196133 |
| 178 | Delayed gross motor development (HP:0002194) | 1.64264776 |
| 179 | Abnormality of glycolysis (HP:0004366) | 1.64125160 |
| 180 | Increased serum pyruvate (HP:0003542) | 1.64125160 |
| 181 | Heart block (HP:0012722) | 1.63619316 |
| 182 | Spastic gait (HP:0002064) | 1.61111662 |
| 183 | Failure to thrive in infancy (HP:0001531) | 1.60834064 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | LMTK2 | 3.14112424 |
| 2 | STK39 | 2.88927609 |
| 3 | NTRK3 | 2.86895969 |
| 4 | MAP3K9 | 2.68424964 |
| 5 | KSR2 | 2.36221349 |
| 6 | PHKG1 | 2.33139670 |
| 7 | PHKG2 | 2.33139670 |
| 8 | NTRK1 | 2.30184617 |
| 9 | WNK3 | 2.15059084 |
| 10 | MYLK | 2.02425383 |
| 11 | WNK4 | 1.96467742 |
| 12 | LIMK1 | 1.94824566 |
| 13 | ARAF | 1.91989208 |
| 14 | GRK5 | 1.91294848 |
| 15 | AKT3 | 1.90584174 |
| 16 | MINK1 | 1.88054503 |
| 17 | ACVR1B | 1.87305571 |
| 18 | MAP3K2 | 1.80951065 |
| 19 | TRPM7 | 1.80191335 |
| 20 | MAP3K4 | 1.73497093 |
| 21 | FGFR3 | 1.71318483 |
| 22 | MAP3K12 | 1.68623344 |
| 23 | PAK3 | 1.66920183 |
| 24 | TTN | 1.61597623 |
| 25 | PIK3CA | 1.59000935 |
| 26 | LATS2 | 1.58894859 |
| 27 | GRK1 | 1.56764760 |
| 28 | FER | 1.55085845 |
| 29 | STK24 | 1.54606378 |
| 30 | NME1 | 1.53135991 |
| 31 | MAPKAPK5 | 1.52554782 |
| 32 | PTK2B | 1.43155323 |
| 33 | WNK1 | 1.42115843 |
| 34 | CAMK2D | 1.41614888 |
| 35 | RET | 1.38394380 |
| 36 | EPHA4 | 1.37862326 |
| 37 | NLK | 1.34447340 |
| 38 | PAK6 | 1.33853301 |
| 39 | OXSR1 | 1.31849940 |
| 40 | MAP2K6 | 1.31805469 |
| 41 | ROCK2 | 1.24733186 |
| 42 | EPHB1 | 1.23905456 |
| 43 | CASK | 1.21642545 |
| 44 | CAMK2A | 1.19884406 |
| 45 | MAP2K7 | 1.19693179 |
| 46 | BCR | 1.16947269 |
| 47 | MAP2K1 | 1.11995698 |
| 48 | MAP2K4 | 1.11729696 |
| 49 | CAMK2B | 1.09833425 |
| 50 | DDR2 | 1.07879077 |
| 51 | STK3 | 1.07683253 |
| 52 | SGK2 | 1.07281768 |
| 53 | DMPK | 1.06195031 |
| 54 | PDK3 | 1.03876458 |
| 55 | PDK4 | 1.03876458 |
| 56 | PLK2 | 1.01914628 |
| 57 | RIPK1 | 1.01562521 |
| 58 | MST4 | 1.01476658 |
| 59 | PRKAA2 | 1.01294996 |
| 60 | PNCK | 1.01112732 |
| 61 | STK11 | 1.00585518 |
| 62 | CDK5 | 1.00253483 |
| 63 | OBSCN | 0.98609782 |
| 64 | PRKCG | 0.98606779 |
| 65 | PRKCE | 0.98477739 |
| 66 | CAMK2G | 0.98370320 |
| 67 | STK38L | 0.97614952 |
| 68 | CDC42BPA | 0.97107442 |
| 69 | PRKAA1 | 0.91122704 |
| 70 | UHMK1 | 0.90679707 |
| 71 | ADRBK2 | 0.90443703 |
| 72 | MAP3K1 | 0.88430823 |
| 73 | CAMK1G | 0.86894435 |
| 74 | CSNK1G1 | 0.84947431 |
| 75 | PKN1 | 0.84470035 |
| 76 | ROCK1 | 0.83027150 |
| 77 | FRK | 0.81882088 |
| 78 | GRK7 | 0.80752383 |
| 79 | EPHB2 | 0.79124452 |
| 80 | HIPK2 | 0.78579343 |
| 81 | MUSK | 0.78444631 |
| 82 | EPHA3 | 0.76928654 |
| 83 | MAP2K2 | 0.76800002 |
| 84 | SGK3 | 0.76711968 |
| 85 | DAPK2 | 0.75082029 |
| 86 | CDK14 | 0.71903591 |
| 87 | TAOK1 | 0.71043919 |
| 88 | ADRBK1 | 0.70777759 |
| 89 | CSNK1G3 | 0.69524317 |
| 90 | PTK2 | 0.69109855 |
| 91 | PDPK1 | 0.68551603 |
| 92 | MARK1 | 0.68500179 |
| 93 | RIPK4 | 0.64750968 |
| 94 | PINK1 | 0.64170871 |
| 95 | PRKD1 | 0.62517480 |
| 96 | CAMK1 | 0.62369012 |
| 97 | CDK19 | 0.62342036 |
| 98 | MAP3K7 | 0.61949376 |
| 99 | JAK1 | 0.61665626 |
| 100 | SGK1 | 0.61215597 |
| 101 | CAMKK2 | 0.61174104 |
| 102 | SGK223 | 0.61089021 |
| 103 | SGK494 | 0.61089021 |
| 104 | MAP3K13 | 0.61073719 |
| 105 | YES1 | 0.60791921 |
| 106 | FGFR4 | 0.60566826 |
| 107 | MAP4K2 | 0.60095667 |
| 108 | FGR | 0.59437711 |
| 109 | CSNK1G2 | 0.59430593 |
| 110 | MET | 0.57074442 |
| 111 | MAPK13 | 0.56134686 |
| 112 | TNIK | 0.56037196 |
| 113 | KSR1 | 0.55707916 |
| 114 | PDK2 | 0.55405311 |
| 115 | CDK18 | 0.53940400 |
| 116 | TIE1 | 0.53684160 |
| 117 | CDK15 | 0.52550530 |
| 118 | ERBB4 | 0.52039454 |
| 119 | PRKG1 | 0.51138287 |
| 120 | CSNK1A1 | 0.49950897 |
| 121 | PRKACA | 0.49114327 |
| 122 | BMPR1B | 0.48578852 |
| 123 | TESK1 | 0.47894260 |
| 124 | INSRR | 0.47772930 |
| 125 | PDGFRA | 0.46253978 |
| 126 | PDK1 | 0.45641775 |
| 127 | PRKCZ | 0.45471110 |
| 128 | FGFR2 | 0.45228363 |
| 129 | PRKACB | 0.44952312 |
| 130 | PRKD3 | 0.44355795 |
| 131 | CAMKK1 | 0.43255159 |
| 132 | PRKCA | 0.42713879 |
| 133 | NTRK2 | 0.42601227 |
| 134 | CDK11A | 0.41715137 |
| 135 | PRKCH | 0.41617973 |
| 136 | DAPK3 | 0.41343558 |
| 137 | EPHA2 | 0.40364130 |
| 138 | CAMK1D | 0.38521165 |
| 139 | PRKACG | 0.38431626 |
| 140 | TRIM28 | 0.38258244 |
| 141 | IRAK1 | 0.36777049 |
| 142 | RPS6KA3 | 0.34049486 |
| 143 | PRKG2 | 0.33963540 |
| 144 | STK4 | 0.33885314 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 4.71079428 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.79977680 |
| 3 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.61970977 |
| 4 | Parkinsons disease_Homo sapiens_hsa05012 | 2.44184981 |
| 5 | Alzheimers disease_Homo sapiens_hsa05010 | 2.14584006 |
| 6 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.09350818 |
| 7 | Nicotine addiction_Homo sapiens_hsa05033 | 2.02596344 |
| 8 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.97175528 |
| 9 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.87775772 |
| 10 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.82987438 |
| 11 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.79827754 |
| 12 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.70837212 |
| 13 | GABAergic synapse_Homo sapiens_hsa04727 | 1.70233278 |
| 14 | Salivary secretion_Homo sapiens_hsa04970 | 1.63283304 |
| 15 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.61483652 |
| 16 | Circadian entrainment_Homo sapiens_hsa04713 | 1.59294371 |
| 17 | Taste transduction_Homo sapiens_hsa04742 | 1.57483846 |
| 18 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.57237640 |
| 19 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.55945584 |
| 20 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.53600819 |
| 21 | Circadian rhythm_Homo sapiens_hsa04710 | 1.49999713 |
| 22 | Long-term potentiation_Homo sapiens_hsa04720 | 1.48817659 |
| 23 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.47764022 |
| 24 | Huntingtons disease_Homo sapiens_hsa05016 | 1.45894550 |
| 25 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.42116304 |
| 26 | Morphine addiction_Homo sapiens_hsa05032 | 1.40930073 |
| 27 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.40522659 |
| 28 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.39086327 |
| 29 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.38595395 |
| 30 | Olfactory transduction_Homo sapiens_hsa04740 | 1.37773284 |
| 31 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.37708136 |
| 32 | Protein export_Homo sapiens_hsa03060 | 1.37481309 |
| 33 | Insulin secretion_Homo sapiens_hsa04911 | 1.30866499 |
| 34 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.30852387 |
| 35 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.30026084 |
| 36 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.29609893 |
| 37 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.27969893 |
| 38 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.25389784 |
| 39 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.21531852 |
| 40 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.21021558 |
| 41 | Renin secretion_Homo sapiens_hsa04924 | 1.20945130 |
| 42 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.20584360 |
| 43 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.14070239 |
| 44 | Long-term depression_Homo sapiens_hsa04730 | 1.13556958 |
| 45 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.13222508 |
| 46 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.12641861 |
| 47 | Axon guidance_Homo sapiens_hsa04360 | 1.09758277 |
| 48 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.09412545 |
| 49 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.07968075 |
| 50 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.07672075 |
| 51 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.03392414 |
| 52 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.02421414 |
| 53 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.02375206 |
| 54 | Gap junction_Homo sapiens_hsa04540 | 1.01706461 |
| 55 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.01610491 |
| 56 | Cocaine addiction_Homo sapiens_hsa05030 | 0.98756054 |
| 57 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.97949609 |
| 58 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.97906591 |
| 59 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.96607765 |
| 60 | Bile secretion_Homo sapiens_hsa04976 | 0.96218536 |
| 61 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.94934595 |
| 62 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.94856796 |
| 63 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.94499820 |
| 64 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.94279531 |
| 65 | Histidine metabolism_Homo sapiens_hsa00340 | 0.88090976 |
| 66 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.88052568 |
| 67 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.87863980 |
| 68 | Phototransduction_Homo sapiens_hsa04744 | 0.86734018 |
| 69 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.83825694 |
| 70 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.83795736 |
| 71 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.83427705 |
| 72 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.83394035 |
| 73 | Tight junction_Homo sapiens_hsa04530 | 0.81821449 |
| 74 | Melanogenesis_Homo sapiens_hsa04916 | 0.81189314 |
| 75 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.80518908 |
| 76 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.79802087 |
| 77 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.78997908 |
| 78 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.78919808 |
| 79 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.78679088 |
| 80 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.78578043 |
| 81 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.77967623 |
| 82 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.75840979 |
| 83 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.75168314 |
| 84 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.74783598 |
| 85 | ABC transporters_Homo sapiens_hsa02010 | 0.74525657 |
| 86 | Other glycan degradation_Homo sapiens_hsa00511 | 0.74416207 |
| 87 | Peroxisome_Homo sapiens_hsa04146 | 0.74298499 |
| 88 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.73227756 |
| 89 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.73100434 |
| 90 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.72755602 |
| 91 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.72657582 |
| 92 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.68744175 |
| 93 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.66725585 |
| 94 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.66185089 |
| 95 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.64917113 |
| 96 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.64429103 |
| 97 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.64078475 |
| 98 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.62676904 |
| 99 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.62433189 |
| 100 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.62098872 |
| 101 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.61658936 |
| 102 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.60914760 |
| 103 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.60498846 |
| 104 | Focal adhesion_Homo sapiens_hsa04510 | 0.60308396 |
| 105 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.60221557 |
| 106 | Lysosome_Homo sapiens_hsa04142 | 0.58858828 |
| 107 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.58235421 |
| 108 | Retinol metabolism_Homo sapiens_hsa00830 | 0.57059437 |
| 109 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.57003218 |
| 110 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.55823240 |
| 111 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.55234393 |
| 112 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.54812306 |
| 113 | Glioma_Homo sapiens_hsa05214 | 0.53911591 |
| 114 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.53580141 |
| 115 | Melanoma_Homo sapiens_hsa05218 | 0.52755335 |
| 116 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.52612963 |
| 117 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.52584760 |
| 118 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.50551569 |
| 119 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.49950550 |
| 120 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.49647097 |
| 121 | Mineral absorption_Homo sapiens_hsa04978 | 0.49508848 |
| 122 | Insulin resistance_Homo sapiens_hsa04931 | 0.48994759 |
| 123 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.48345512 |
| 124 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.47348029 |
| 125 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.46523726 |
| 126 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.46246400 |
| 127 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.45754248 |
| 128 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.45510721 |
| 129 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.43862986 |
| 130 | Endocytosis_Homo sapiens_hsa04144 | 0.43247158 |
| 131 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.41667940 |
| 132 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.41564034 |
| 133 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.40020247 |
| 134 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.39963940 |
| 135 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.38806764 |
| 136 | Amoebiasis_Homo sapiens_hsa05146 | 0.37682340 |
| 137 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.35971501 |
| 138 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.35905433 |
| 139 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.33132439 |

